Targeted Thrombolytic Liposomes

CLC Number:

Supporting:

WANG Xiang-tao, HOU Xin-pu^*. Targeted Thrombolytic Liposomes[J]. .

[1]	Huan Chen, Danping Zheng, Xiaoyan Liu, Yuanjun Zhu, Yinye Wang. Design, preparation and activity evaluation of two novel proteins with thrombolysis or/and neuroprotection [J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(11): 787-798.
[2]	Yanan Zhu, Yuanjun Zhu, Qixin Bu, Xiaoyan Liu, Yinye Wang*. rAcAP5: high-yield strain screening, expression, purification and thrombolytic effect evaluation in rat embolic middle cerebral artery occlusion model [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(1): 22-27.
[3]	Chun-Lei Luo, Hui Zhao, Jian-Cheng Wang, Xuan Zhang, Wan-Liang Lu, Qiang Zhang^. In vitro* characterization of two new doxorubicin liposomes modified with argine-glycine-aspartic acid tripeptide or glycine-argine-glycine-aspartic acid-serine pentapeptide [J]. , 2007, 16(3): 162-169.
[4]	Ming Zhao, Shi-Qi Peng, Meng-Shen Cai, Chao-Shu Tang, Chang-Ling Li, Xue-Min Yu, Zhen-Nan Wang . Antiplatelet Aggregation and Vasodilation Effects of RGDS [J]. , 1993, 2(1): 18-23.

PDF (PC)